News | Mammography | March 08, 2018

Fujifilm Debuts Aspire Bellus II Multimodality Mammography Workstation

The latest workstation will be on display this spring at the National Consortium of Breast Centers (NCoBC) conference and the Society of Breast Imaging (SBI) Symposium.

 

Fujifilm Debuts Aspire Bellus II, A New Multimodality Mammography Workstation

March 8, 2018 –   Fujifilm Medical Systems U.S.A. Inc., a provider of diagnostic imaging products with a comprehensive portfolio of women’s health solutions, will unveil its latest mammography diagnostic workstation, the Aspire Bellus II, at the National Consortium of Breast Centers (NCoBC) conference, March 9 -14, 2018, in Las Vegas and the Society of Breast Imaging (SBI) Symposium, April 12 -15, 2018, also in Las Vegas.

The Aspire Bellus II smart mammography workstation offers a multimodality view for radiologists in a hi-resolution display, and also offers 2-D and tomosynthesis comparisons. While supporting a range of DICOM formats, the system is designed around the unique requirements of mammography. The Aspire Bellus II incorporates key diagnostic features such as current and prior image comparison, quadrant view, tomosynthesis support and invert. To optimize workflow the workstation enables customization for reading protocols and personalized configuration. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in September 2017 and will begin shipping to customers in spring 2018.

At both conferences, Fujifilm will also exhibit the Aspire Cristalle digital mammography system with digital breast tomosynthesis (DBT) option. It combines Hexagonal Close Pattern (HCP) image capture technology and intelligent image processing, optimizing both contrast and dose based on auto recognition of breast characteristics. This technology is designed to optimize image acquisition, regardless of breast composition and at a low dose. In addition, the Aspire Cristalle helps deliver noticeable patient comfort with its patented, flexible Comfort Paddle intended to provide gentle, even compression of the breast.

For more information: www.fujimed.com 

Related Content

Right mediolateral oblique (MLO) mammograms for different women with the same breast thickness but varying breast density.

Right mediolateral oblique (MLO) mammograms for different women with the same breast thickness but varying breast density.

News | Breast Imaging | July 30, 2021
July 30, 2021 — Volpara Health, a global health technology software leader providing an integrated breast care platfo
Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has signed an agreement with Invitae Corporation, a leader in medical genetics, to bring Invitae's genetic testing services to Volpara's customers in the United States. 
News | Breast Imaging | July 29, 2021
July 29, 2021 — Volpara Health, a global health technology software leader providing an...
Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
July 16, 2021 —...
Volpara now holds 98 granted patents across 27 countries
News | Breast Imaging | July 16, 2021
July 16, 2021 — Volpara has recently been granted another patent by the...
Interviews with the 1,000 at-risk patients also led to some interesting conclusions, Fine said. Even in the early days of 3D mammography, most women interviewed had at least heard about the technology.

Getty Images

News | Mammography | July 15, 2021
July 15, 2021 —  For any type of diagnostic test, technology that helps improve the reliability of test results is a
ujifilm's robust medical systems portfolio includes a comprehensive product lineup covering CT, MRI, fluoroscopy, digital radiography, women’s health, ultrasound, systems integration, endoscopy and endosurgery, enterprise imaging, assisted reproductive technology, cell culture media, cell therapy development, In-Vitro diagnostics (IVD), and investigational drug development
News | Radiology Imaging | July 14, 2021
July 14, 2021 — Fujifilm announced the launch of the ...
A new study set out to learn more about breast health for Black women and to establish a better understanding of the breast screening landscape by analyzing mammograms, screening intervals and interpretation performance for Asian, Black and white women across health systems throughout the United States, with participation from Advocate Health Care, Sanford Health and the University of Pennsylvania Health System.

Getty Images

Feature | Breast Imaging | July 06, 2021 | By Linda Goler Blount, MPH
Due to dangerous implications for years to come, facilities must increase efficiency and capacity for breast cancer care to recover from the impact of COVID-19

Getty Images

Feature | Breast Imaging | July 06, 2021 | By Ananth Ravi, Ph.D.
The challenges